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somal region must have greater biological
importance than simply to create problems
for the transplant surgeon? An increasing
knowledge of associations between HLA and
disease, presumably based on linkage dis-
equilibrium between MHC and disease genes,
may in the future give clues to the role of
aetiological factors (viruses?) involved in
the induction of cancer, and it mav not be
too long before a future Workshop will be
considering these questions.
G. M. TAYLOR
Transplantation Reviews 26: Suppressor
T Lymphocytes. Ed. GORAN MOLLER.
(1975). Copenhagen: Munksgaard. 205 pp.
Price £11.30.
When Transplantation Reviews were first
published 7 years ago it seemed that they
might emerge once a year or so. Twenty-
six volumes and 7 years later this happy
expectation is seen to have been baseless.
The intervening volumes span a bewildering
array of contemporary immunology with a
strong cellular bias. The adjectival " Trans-
plantation " has not always been appropriate.
The policy of the editor in chief has
been to take a topical theme and encourage
a number of the contemporary virtuosi
to expand on it in their own words and
exemplify, largely by their own experiments,
the subject to hand. Thus not only has
the "Transplantation " been misleading but
the" Review " is only correct in the theatrical
sense.
The latest volume of these reviews is on
suppressor T cells. The notion, attributable
to Gershon, is that the sequelae of antigenic
stimuli should be supposed to have an
intrinsic duality-a sort of immunological
yin and yang. On the one hand " T "
(thymus-derived) helper cells will facilitate
antibody production by B cells. On the
other hand " T " (still thymus-derived)
suppressor cells will, as their name suggests
prevent antibody production. Both T-H
and T-8, as one might call them, are thought
to have specificity of action. As Gershon
says in his article " the mechanism by which
T cells suppress is the reverse of the way
that helper cells help ". It should be pointed
out that the suppressor argument is largely
if not entirely restricted to situations in
which humoral antibody production is elicited
(or prevented as the case may be). It
is not usually supposed that the suppressive
effect is mediated from antibody-derived
B cells nor by factors produced by macro-
phages. It is of course recognized that both
antibody and macrophage-derived factors
can have cell-suppressive effects and that
specific T cell triggers for these factors
exist. Despite these difficulties of deciding
which member ofthe immunological orchestra
is actually playing at any one moment in
time, the protagonists of T cell suppression
envisage that their favourite cells operate
either directly on B cells to prevent antibody
production or, alternatively, that they pro-
duce some factor which diffuses from T to
B to have the same effect.
The concept of suppressor cells recognizes
that, in any metazoan, mitosis in a closed
system could have dire consequences, and
proposes that there is an in-built control
mechanism. On the same basis, students
of regeneration of the liver after partial
hepatectomy should look for suppressor
hepatocytes-and indeed they might find
them.
There are 9 studies of T cell suppressors
in the present volume. The first by Baker
is unique in that it concerns the role of T
cells in suppressing a " thymus-independent "
immune response against pneumococcal poly-
saccharide (SSS-JII). Baker's case is broadly
that in certain situations in which T cell
numbers have been reduced by antilympho-
cyte antiserum the plaque-forming cell
response to SSS-III is augmented. Baker
prefers to think of regulatory and amplifier
T cells. He advances the notion that
recognition by regulatory T cells of idiotypic
determinants on B cells could facilitate
their role and points out that comparable
regulation could be achieved by auto-anti-
idiotypic antibodies operating humorally.
A thoughtful paper, if over emphatic in
its weaker sections. Those new to sup-
pressors should try this one first.
Benacerraf and his colleagues describe
how they suppose that various genetically
non-responder strains of mice are potentially
responsive but simply have suppressor T
cells which are activated after the receipt
of the antigen to which there is not a positive
response. They describe how the putative
T-S cells produce a factor which could be
a product of certain genes within the H-2
complex-a finding in line with the resultsBOOK REVIEWS 99
of Tada which are recorded elsewhere in
the book.
Dutton describes how h-e finds suppressor
T cells in vitro, produced as a consequence
of addition of concanavalin A. He feels
that despite its artificiality the in vitro
system, non-specifically induced, has much
to offer a model of suppressive activity in
vtvo.
Kolsch and Nachtigal, and Basten and
Weigle and their respective colleagues all
contribute pieces on tolerance and sup-
pressor cells where the specific states of
unresponsiveness described as immunological
tolerance are themselves induced by sup-
pressor T cells-a notion not far removed
from the original ideas of Gershon.
Gershon's owAn contribution is an exercise
in rhetoric which broadly summarizes much
of what is said elsewhere in the book and
concludes with the phrase " further work is
required before a full understanding of the
importance, mechanism of action and other
aspects of the suppressor T cell function can
be fully understood ".
The book fails to establish that T-S
cells are in fact a discrete population with
a definite ontogenetic pattern which is
different from that of helper cells. Gershon
(personal communication) says that the
evidence is to hand on the basis of studies
with anti-ly antisera, but at the moment
they must be regarded as an interesting
concept rather than factual, and relevant to
clinical medicine.
This book is valuable if it is viewed for
what it is-a collection of sketches by
skilful artists. If it is taken literally, it
will drive the reader to distraction or un-
thinking belief. My preference wNould be
to see some editorial comment from time
time-then perhaps few%er such reviews would
be published.
A. J. S. DAVIES
Corynebacterium parvum. Applications
in Experimental and Clinical Oncology.
Ed. B. HALPERN (1975). New York:
Plenum Press. 444 pp. Price $45.00
net.
Corynebacterium parvum, a potent stimu-
lator of the reticuloendothelial system, is
one of a number of agents now being evaluat-
ed for " adjuvant immunotherapy ofcancer ".
Perhaps not surprisingly, a bewildering
array of responses are produced in hosts
treated with C. parvum, although activation
of macrophages may be considered as one
of the significant effects. Therefore, whilst
the many studies described in this book
dealing wTith therapy of experimental animal
tumours show quite conclusively that C.
parvum can be effective, one is left with the
feeling that there is no consensus of opinion
as to its mode of action. Moreover, the
w%ide array of experimental animal tumour
systems used is confusing to the non-
specialist especially since some transplanted
tumours in allogeneic hosts (e.g. murine
sarcoma S180) are totally irrelevant to
human cancer. On reading the papers one
is left with the feeling that more standardized
test systems, such as those employed in
cancer chemotherapy screening, will be
necessary.
The experimental tumour studies show
that C. parvum can be effectively employed
for the treatment of localized as well as
disseminated disease. Furthermore, the po-
tential of this agent in the treatment of
human malignant disease is emphasized by
the preliminary clinical trials described in
the book. Again, however, the lack of
suitable methods for monitoring therapy
with immunostimulating agents is emphas-
ized and this must be overcome if any real
progress is to be achieved.
This volume will be of considerable
value to cancer research workers since it
draws together a series of interesting papers
on the pharmacology and immunology of C.
parvuin. It will have no appeal to the
more general reader and is certainly not
to be considered as a " source book " on
immunostimulants for cancer treatment.
R. W. BALDWIN
Molecular Pathology. Ed. R. A. GOOD,
S. B. DAY and J. J. YUNIS (1975). IL-
linois: Charles C. Thomas. 870 pp. Price
$67.50.
The editors set out their aims to focus
recent advances in experimental pathology
into a new discipline. While not discounting
" the Virchowian concept ", they suggest
that the present knowledge of disease at a
subcellular level and collaboration of pre-
viously diverse specialities should soon bring
practical advances in the understanding and
treatment of many diseases. The book is